Take Solutions Q4 Results
- BSE: 532890
- NSE: TAKE
- ISIN: INE142I01023
- Sector: Biotechnology & Drugs
BSE
29.73
-0.03 (-0.10%)
-0.03 (-0.10%)Volume37.04 K
Updated: Mon 15 Jun, 2026 | 15:40:59
NSE
29.53-0.14 (-0.47%)
-0.14 (-0.47%)Volume1.57 L
Updated: Mon 15 Jun, 2026 | 15:41:15
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Incomeâ‚ą54.19 Cr.(NA%)
- Operating Profitâ‚ą-0.83 Cr.(-28.14%)
- Profit After Taxâ‚ą4.36 Cr.(1334.18%)
- Operating Margin-1.52%(NA%)
Note: Comparison is on YoY basis
Quarterly - Take Solutions Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 55.01 | 0.35 | 15554.61% | 54.51 | 4691.84% |
| Depreciation/ Amortization | 0.00 | 0.00 | 0.00% | 0.01 | -80.00% |
| Operating Income | -0.83 | -0.35 | 134.78% | -54.51 | -28.14% |
| Net Income | 4.36 | 1.11 | 293.10% | -,110.61 | 0.00% |
| Other Operating Expenses Total | 0.79 | 0.21 | 270.95% | 15.33 | -20.42% |
| Net Income Before Taxes | 4.36 | 1.11 | 293.10% | -55.04 | 1334.18% |
| Total Revenue | 54.19 | 0.00 | 0.00% | 0.00 | 0.00% |
| Selling/ General/ Admin Expenses Total | 0.01 | 0.14 | -89.21% | 0.43 | -89.57% |
| Diluted Normalized EPS | 0.29 | 0.07 | 314.29% | -2.08 | 1300.29% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
âś•
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.